Published May 6, 2020 | Version v1

Bibliometric Study of International Scientific Production on the Novel Coronavirus COVID-19

  • 1. University of Fortaleza, UNIFOR, Fortaleza, CE, Brazil
  • 2. Faculty of Exact Human Sciences and Health of Piauí -FAHESP / Institute of College Education of Vale do Parnaíba, IESVAP, Parnaíba, PI, Brazil

Description

Abstract

The Novel Coronavirus COVID-19 was first identified in China and became a global health problem due to its pathogenicity and widespread distribution around the world. On March 11, the World Health Organization declared COVID-19 a global pandemic, its first designation since it declared H1N1 flu a pandemic in 2009. This study aims to map international scientific production on the Novel Coronavirus. The search term “COVID-19” was used in the ISI Web of Knowledge / Web of ScienceTM database, analysing the records that present the term selected for the search. As a methodological path, a bibliometric research was carried out in academic works on the Web of ScienceTM, identifying, after applying the refinement filters, 64 publication records in 36 different journals. As the main results of the analyses, the top journals of the theme and the most cited articles were identified. Although this research does not cover all scientific production information about the new Corona virus “COVID-19”, it was possible to search for documents of high scientific relevance so that we have an overview of the scientific production world on the subject.

Introduction

Coronaviruses are enveloped RNA viruses that are widely distributed among humans, other mammals and birds and that cause respiratory, enteric, liver and neurological diseases [1,2]. Although these viruses generally have low pathogenicity, two epidemics have occurred on the last two decades: the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002 and the Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012, both emerging from animal reservoirs to cause global occurrence in humans with alarming morbidity and mortality [3].

In late December 2019, Chinese authorities reported clusters of patients with pneumonia of unknown cause that were epidemiologically linked to a large market selling many species of live animals in Wuhan, Hubei Province, China [4]. Chinese scientists isolated the virus from a patient in a short time and on January 7, 2020 published the sequencing of the SARSCoV-2 genome, thus facilitating the monitoring of the evolution of the virus around the globe [5]. On January 30, 2020, World Health Organization (WHO) declared the COVID-19 outbreak a global health emergency and on March 11, 2020, it declared COVID-19 a global pandemic, its first designation since it declared H1N1 flu a pandemic in 2009 [6].

As of March 20, 2020, the COVID-19 was affecting 186 countries and territories around the world and 1 international conveyance (the Diamond Princess cruise ship harboured in Yokohama, Japan). There had been 234,073 confirmed cases of COVID-19 and 9,840 deaths at that time [7].

The rapid progression and little knowledge of the infection by COVID-19, opened the eyes of researchers spread by the globe in the search for more information, definitions, analyses and studies about the pathogen and its interaction with the human body. Much already has been published in the last months and we have objectives to make a bibliometric study. An earlier bibliometric analysis evaluated the scientific literature on different coronaviruses [8], but this study aims to map international scientific production on the SARS-CoV-2.

Notes

International Journal of Clinical and Medical Cases (ISSN:2517-7346)

Files

IJCMC-3-155.pdf

Files (1.2 MB)

Name Size
md5:ac2924f1d79e0ef8867aa8b6d1cc2f09
1.2 MB Preview Download

Additional details

References

  • WEISS SR, LEIBOWITZ JL. Coronavirus Pathogenesis. Advances In Virus 181 Research. Elsevier 2011;85-164.
  • Masters PS, Perlman S. Coronaviridae. In: Knipe DM, Howley PM, eds.Fields virology. 6th ed. Lippincott Williams & Wilkins, 2013;825-58.
  • CUI Jie, Fang LI, Zheng-li SHI. Origin and evolution of pathogeniccoronaviruses. Nature Reviews Microbiology. 2018;17:181-192.
  • Wuhan Municipal Health Commission, Report of clustering pneumonia of unknown etiology in Wuhan City, 2019.
  • Lu R, Zhao X1, Li J, Niu P, Yang B, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor 194 binding. The Lancet. 2020 Feb;395(10224):565-574.
  • WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February2020.
  • WHO. Coronavirus disease 2019 (COVID-19): Situation Report – 60. 2020.
  • Bonilla-Aldana DK, Quintero-Rada K, Montoya-Posada JP, Ramírez Ocampo S, Paniz-Mondolfi, et al. ASARS-CoV, MERS-CoV and now the2019-novel CoV: Have we investigated enough about coronaviruses?– A bibliometric analysis. Travel Med Infect Dis. 2020 Jan -Feb;33:101566.
  • Peng Z, Xing-lou Y, Xian-guang W, Ben H, Lei Z, et al. A pneumoniaoutbreak associated with a new coronavirus of probable bat origin.Nature. 2020;579:270-273.
  • Chen N, Zhou M, Dong X, Qu J, Gong F, et al. Epidemiological andclinical characteristics of 99 cases of 2019 novel coronaviruspneumonia in Wuhan, China: a descriptive study. Lancet. 2020Feb;395(10223):507-513.
  • Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, et al. Clinical Characteristicsof Coronavirus Disease 2019 in China. N Engl J Med. 2020Apr;382(18):1708-1720.
  • Wei-jie G, Zheng-yi NI, Yu HU, Wen-hua LIANG, Chun-quan OU, et al.Clinical Characteristics of Coronavirus Disease 2019 in China. N EnglJ Med 2020 Apr;382:1708-1720.
  • Huang C, Wang Y, Li X, Ren L, Zhao J. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020Feb;395(10223):497-506.
  • Wang M, Cao R, Zhang L, Yang X, Liu J, et al. Remdesivir and chloroquineeffectively inhibit the recently emerged novel coronavirus (2019-nCoV) invitro. Cell Res. 2020 Mar;30(3):269-271.
  • CHAN Jasper Fuk-woo, YUAN Shuofeng, KOK Kin-hang, Kelvin Kaiwang, CHU Hin, et al. A familial cluster of pneumonia associated withthe 2019 novel coronavirus indicating person-to-person transmission:a study of a family cluster. The Lancet. 2020 Feb;514-523.
  • Zhu N, Zhang D, Wang W, Li X, Yang B, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020Feb;382(8):727-733.
  • Wang D, Hu B, Hu C, Zhu F, Liu X, et al. Clinical Characteristics of138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020 Feb.
  • Li Q, Guan X, Wu P, Wang X, Zhou L, et al. Early Transmission Dynamicsin Wuhan, China, of Novel Coronavirus–Infected Pneumonia. N Engl JMed. 2020 Mar;382(13):1199-1207.